Tobias Lite | 45.7mg Per Tablet

Alkaloid Profile (Per Tablet)

Total Alkaloid Content: 45.70 mg

7-Hydroxymitragynine: 98.73% (45.12mg)

Mitragynine Pseudoindoxyl: 1.27% (0.58mg)

Packaging Information

Packaging: Dark blue to light blue gradient mylar

Single Pack: 5 tablets per pack

Multipack: 50 tablets per pack

Product Description

Tobias Lite is an ultra-high-strength tablet formulation designed exclusively for experienced users seeking powerful, long-lasting relief with a controlled and predictable onset. Manufactured using precision Thai Style pressing and verified through third-party lab testing, this product prioritizes consistency, integrity, and performance.

The formulation is heavily centered around 7-Hydroxymitragynine to deliver pronounced physical relief and deep relaxation, while a measured amount of Mitragynine Pseudoindoxyl adds balance and stability to the overall experience. This pairing produces a steady, controlled build rather than an abrupt spike, allowing effects to develop evenly and remain sustained.

Tobias Lite is intended for individuals with established tolerance who require significant support for prolonged discomfort or demanding routines. Its profile emphasizes depth, duration, and reliability, making it one of the most potent offerings in the lineup while maintaining structural balance.

Caution & Responsible Use

This is not a beginner product. Tobias Lite contains a very high total alkaloid concentration and should be approached with care, even by seasoned users. Start with a small amount, allow ample time to fully assess individual response, and avoid redosing prematurely. Responsible, measured use is essential to ensure a safe and controlled experience.

This product is not available for shipment to the following states: Alabama, Arkansas, Indiana, Rhode Island, Wisconsin, Florida; or the following counties: San Diego (California), Oceanside (California), Alton (Illinois), Jerseyville (Illinois), Edwardsville County (Illinois), Columbus (Mississippi), Union County (Mississippi), Ascension (Louisiana), Franklin (Louisiana), Ohio, and Rapides (Louisiana).

FDA Disclaimer:

The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease.

Kratom products have not been evaluated or approved by the U.S. Food and Drug Administration (FDA) for safety, effectiveness, or as a treatment for any medical condition. The information provided on this website is for educational purposes only and should not be construed as medical advice. Kratom is not intended to diagnose, treat, cure, or prevent any disease.